Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Research Square|June 12, 2025
Integrated PTSD and Adherence Treatment for People with HIV: Main Findings of a Feasibility Pilot for Cognitive Processing Therapy- Lifesteps (CPT-L)Cristina López, Nathaniel Baker, Stephanie Amaya, et al.Journal of Biomechanics|June 9, 2016
Efavirenz and ritonavir-boosted lopinavir use exhibited elevated markers of atherosclerosis across age groups in people living with HIV in EthiopiaRudolph L Gleason, Alexander W Caulk, Daniel Seifu, et al.AIDS Research and Therapy|October 29, 2025
Integrated PTSD and adherence treatment for people living with HIV: a feasibility pilot trial for cognitive processing therapy- lifesteps (CPT-L) at a Ryan white clinicCristina M López, Nathaniel Baker, Stephanie Amaya, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2017
Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-Infected YouthAllison Ross Eckard, Mary Ann OʼRiordan, Julia C Rosebush, et al.Virulence|March 22, 2017
Arterial stiffness in HIV-infected youth and associations with HIV-related variablesAllison Ross Eckard, Paolo Raggi, Joshua H Ruff, et al.The Pediatric Infectious Disease Journal|September 15, 2016
Increased Immune Activation and Exhaustion in HIV-infected YouthAllison Ross Eckard, Julia C Rosebush, S Thera Lee, et al.JMIR Formative Research|January 17, 2025
Assessment, Decision, Adaptation, Production, Topical Experts-Integration, Training, and Testing (ADAPT-ITT) Framework to Tailor Evidence-Based Posttraumatic Stress Disorder Treatment for People With HIV to Enhance Engagement and Adherence: Qualitative Results from a Feasibility Randomized Controlled TrialCristina M Lopez, Angela D Moreland, Stephanie Amaya, et al.Antiviral Therapy|March 23, 2017
Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activationAllison Ross Eckard, Julia C Rosebush, Mary Ann O'Riordan, et al.Antiviral Therapy|October 11, 2017
Vitamin D supplementation decreases immune activation and exhaustion in HIV-1-infected youthAllison Ross Eckard, Mary Ann O'Riordan, Julia C Rosebush, et al.Journal of the Pediatric Infectious Diseases Society|September 4, 2015
Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of AgeNatasha B Halasa, Michael A Gerber, Andrea A Berry, et al.Pageof 5